After four years and 2,524 enrolled patients, the COMPPARE team officially closed patient accrual to the study on October 31, 2022 at 11:59 p.m…
The COMPPARE Coordinating Center announced today that the study has enrolled its 1,000th photon prostate cancer patient to reach 67% of its photon…
If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test…
Study goals and details.
Updates and resources for patients.
COMPPARE clinicians, researchers, patients, and other stakeholders
For Healthcare providers
Study-specific materials and other information.
Privately and publicly funded clinical studies conducted around the world.
Medical Team sign-in page